Investment Highlights
Disruptive MedTech Solution
-
Therapnea™ is a novel, patented technology to treat Obstructive Sleep Apnea (OSA)
-
Successful Proof of Concept clinical trial
-
Greatly improves patient health, experience & lifestyle
Experienced Team
-
50 combined years of experience in the sleep related fields & decades of experience in MedTech and government regulations
-
Serial entrepreneurs with track record of successful exits
-
The company has raised $2.24M to date
-
Uniquely qualified Scientific Advisory Board with experience in clinical product development
Untapped Global Market
-
Large global market looking for a new solution
-
Life-threatening chronic sleep condition affects 12% of adults¹
-
Competing technology (CPAP) is 40+ years old with up to 50% of patients intolerant of its discomforts²
Blue Ocean Strategy
-
Expected immediate demand from patients intolerant of CPAP
-
Consumer acceptance of our same-price positioning
-
Extensive engagement of Key Opinion Leaders (KOLs)
-
Market education to raise awareness of our novel OSA solution
-
Leverage local manufacturing to reduce OpEx